Pentoxifylline versus prednisolone for severe alcoholic hepatitis: A randomized controlled trial

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 15, Issue 13

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

643

HTML

7913

Figures (1-2)

271

Tables (1-5)

264

Sum=9091

Apr 7, 2009 (publication date) through Feb 14, 2025

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Articles

World J Gastroenterol. Apr 7, 2009; 15(13): 1613-1619
Published online Apr 7, 2009. doi: 10.3748/wjg.15.1613

Table 2 Causes of death in patients receiving pentoxifylline or prednisolone in the treatment of severe alcoholic hepatitis (n = 34)

Citation: De BK, Gangopadhyay S, Dutta D, Baksi SD, Pani A, Ghosh P. Pentoxifylline versus prednisolone for severe alcoholic hepatitis: A randomized controlled trial. World J Gastroenterol 2009; 15(13): 1613-1619
URL: https://www.wjgnet.com/1007-9327/full/v15/i13/1613.htm
DOI: https://dx.doi.org/10.3748/wjg.15.1613